Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial
比较一线姑息化疗方案 EOX 和 mDCF 治疗局部晚期不可切除或转移性 HER2 阴性胃癌或胃食管交界处腺癌患者的疗效和安全性：一项随机 3 期试验
期刊:Medical Oncology
影响因子:3.5
doi:10.1007/s12032-015-0687-7
Ochenduszko, Sebastian; Puskulluoglu, Miroslawa; Konopka, Kamil; Fijorek, Kamil; Urbanczyk, Katarzyna; Budzynski, Andrzej; Matlok, Maciej; Lazar, Agata; Sinczak-Kuta, Anna; Pedziwiatr, Michal; Krzemieniecki, Krzysztof
